Zobrazeno 1 - 10
of 117
pro vyhledávání: '"Nora M. Hansen"'
Genetic Considerations in the Locoregional Management of Breast Cancer: a Review of Current Evidence
Autor:
Omar Bushara, Nora M. Hansen
Publikováno v:
Current Breast Cancer Reports. 15:48-57
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7d6cecef0bc7841808d56f2b2618c95c
https://doi.org/10.1007/s12609-023-00478-2
https://doi.org/10.1007/s12609-023-00478-2
Autor:
Raymond C. Bergan, Margerie Coomes, Alexander Dew, Kevin P. Bethke, Nora M. Hansen, Jun Wang, Maarten C. Bosland, Adrian A. Franke, Borko D. Jovanovic, Irene B. Helenowski, Carola M. Zalles, Richard Heinz, David Ivancic, Oukseub Lee, Michelle Bryk, Nancy Michel, Robert T. Chatterton, Seema A. Khan
PDF file - 44K, Hormone and protein concentrations in nipple aspiration fluid (NAF) samples
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::75909111d185b72b4ae7db2afe370d17
https://doi.org/10.1158/1940-6207.22525599.v1
https://doi.org/10.1158/1940-6207.22525599.v1
Autor:
Raymond C. Bergan, Margerie Coomes, Alexander Dew, Kevin P. Bethke, Nora M. Hansen, Jun Wang, Maarten C. Bosland, Adrian A. Franke, Borko D. Jovanovic, Irene B. Helenowski, Carola M. Zalles, Richard Heinz, David Ivancic, Oukseub Lee, Michelle Bryk, Nancy Michel, Robert T. Chatterton, Seema A. Khan
PDF file - 42K, Changes in cellular parameters for equol producers compared to control women, shown as the differences in post-intervention and baseline values
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21b9456ed6fa9d3e9ba5bf375ceb40a4
https://doi.org/10.1158/1940-6207.22525596.v1
https://doi.org/10.1158/1940-6207.22525596.v1
Publikováno v:
Current Breast Cancer Reports. 13:72-80
Breast cancer is the most common malignancy diagnosed in women worldwide. As the average age of child-bearing increases, more women will not have started or completed their families at the time of a breast cancer diagnosis. The scope of this review i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bc07a3dc44aef13e73d5592ad0cb56fa
https://doi.org/10.1007/s12609-021-00405-3
https://doi.org/10.1007/s12609-021-00405-3
Autor:
Marjorie Perloff, Kelly A. Benante, Shivangi Yadav, Nora M. Hansen, Eileen Dimond, Yanfei Xu, Brandy M. Heckman-Stoddard, Miguel Muzzio, Masha Kocherginsky, Omid Hosseini, Kevin P. Bethke, Mary Beth Tull, Luis Z. Blanco, Irene Helenowski, Seema A. Khan, Oukseub Lee, Melissa A. Troester, Melissa Pilewskie, Scott Karlan
Publikováno v:
Clin Pharmacol Ther
Oral breast cancer prevention medications entail systemic exposure, limiting acceptance by high-risk women. Delivery through the breast skin, although an attractive alternative, requires demonstration of drug distribution throughout the breast. We co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::79a468b81fd0425cfaf40f3d5cbdba84
https://doi.org/10.1002/cpt.2041
https://doi.org/10.1002/cpt.2041
Autor:
Rebecca Aft, Kevin P. Bethke, Julia Tchou, Judy Garber, Nora M. Hansen, Luis Z. Blanco, Al George, Geoffrey L. Greene, Fred Rademaker, Swati Kulkarni, Seema A. Khan, Thea D. Tlsty
Publikováno v:
Cancer Research. 80:OT3-09
Background: TSECs were developed to treat menopausal symptoms after progesterone containing hormone replacement therapy was found to significantly increase the risk of invasive breast cancer (IBC). The first of this class of agents combines conjugate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b7fb494765015a0dec159a0e8017e24f
https://doi.org/10.1158/1538-7445.sabcs19-ot3-09-02
https://doi.org/10.1158/1538-7445.sabcs19-ot3-09-02
Autor:
Susan E. Clare, Chiara Rogers, Peter H. Gann, Yanfei Xu, Megan E. Sullivan, Miguel Muzzio, Kevin P. Bethke, Oukseub Lee, Nora M. Hansen, Hari Singhal, Borko Jovanovic, Zexian Zeng, Ali Shidfar, Seema A. Khan, Irene Helenowski, J. Julie Kim, William J Gradishar
Publikováno v:
Clinical Cancer Research. 26:25-34
Purpose: Selective progesterone receptor modulators (SPRMs) show preclinical activity against hormone-sensitive breast cancer, but have not been tested in patients with early, treatment-naïve tumors. Patients and Methods: In a double-blind presurgic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e3a9ff957d1d3d1762434abbfa4881af
https://doi.org/10.1158/1078-0432.ccr-19-0443
https://doi.org/10.1158/1078-0432.ccr-19-0443
Autor:
Lindsey C. Karavites, Leilani Lacson, Seema A. Khan, Sofia F. Garcia, Kenzie A. Cameron, Margaret R. Moran, Jennifer L. Beaumont, Karen Kaiser, Chiara Rodgers, Nora M. Hansen, Swati Kulkarni
Publikováno v:
Breast Cancer Res Treat
PURPOSE: Newly diagnosed breast cancer patients greatly overestimate their risk of developing contralateral breast cancer (CBC). Better understanding of patient conceptions of risk would facilitate doctor-patient communication and surgical decision m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5375578645f9d6ad4c9ffff8475cf00a
https://doi.org/10.1007/s10549-019-05182-3
https://doi.org/10.1007/s10549-019-05182-3
Autor:
Hiroyuki Abe, Dimple Modgil, Nora M. Hansen, Li Lan, Buxin Chen, David Lester, Sonya Bhole, Ingrid Reiser, Nora Jaskowiak, Dan Xia, Kevin P. Bethke, David V Schacht, Jean Bao, Jennifer F. Tseng, Bidur Bohara, Zheng Zhang, Christian Wietholt, Bazil LaBomascus, Lauren Schulte, Kirti Kulkarni, Xiaochuan Pan, Seema A. Khan, Swati Kulkarni, Jennifer Pincus, Jeffrey Mueller, Xiao Han
Publikováno v:
Annals of Surgical Oncology
Background Two-dimensional (2D) specimen radiography (SR) and tomosynthesis (DBT) for breast cancer yield data that lack high-depth resolution. A volumetric specimen imager (VSI) was developed to provide full-3D and thin-slice cross-sectional visuali
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69391c61d302d83b9a88ea73e64a4a21
https://pubmed.ncbi.nlm.nih.gov/34333705
https://pubmed.ncbi.nlm.nih.gov/34333705
Publikováno v:
Journal of the American College of Surgeons. 227:96-104
Background Rates of mastectomy for breast cancer treatment and immediate reconstruction continue to rise. With increasing scrutiny on outcomes and patient satisfaction, there is an impetus for providers to be more deliberate in appropriate patient se
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a17fe1dbdfaa292bbc20a66262ea627b
https://doi.org/10.1016/j.jamcollsurg.2018.05.003
https://doi.org/10.1016/j.jamcollsurg.2018.05.003